Abstract

SUMMARY Genome-wide association studies have facilitated a substantial and rapid rise in the number of confirmed susceptibility variants for Type 2 diabetes. This has inevitably led to widespread hope that these findings will translate into improved clinical care for the growing numbers of patients with diabetes. This article summarizes recent discoveries in the field of Type 2 diabetes genetics and will discuss their importance and the current obstacles to clinical translation.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.